About Malorin 80 mg/5 ml Syrup
Malorin is a syrup from Albion Laboratories Ltd. that contains Chloroquine Phosphate at a strength of 80 mg/5 ml. It belongs to the anti-malarial group of medicines and comes in a 60 ml bottle.
There are 24 brands of Chloroquine Phosphate listed in Bangladesh. 6 of them have a lower unit price than Malorin. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.
What is Malorin 80 mg/5 ml Syrup?
Malorin Syrup is an anti-malarial medicine containing Chloroquine Phosphate at 80 mg/5 ml, made by Albion Laboratories Ltd. and supplied in a 60 ml bottle. Chloroquine works against the malaria parasite in the blood and is used in the treatment and prevention of malaria. It is also used in some other conditions, including amoebic liver infection and certain joint and skin conditions. Because it can affect the eyes when taken over long periods, regular eye checks may be needed. The doctor decides whether this medicine is suitable for you and how it should be taken.
Uses of Malorin
Malorin Syrup is used for the treatment of malaria and for the prevention and suppression of malaria. It is also used in the treatment of amoebic hepatitis and amoebic abscess, and in the treatment of discoid and systemic lupus erythematosus and rheumatoid arthritis. Only a doctor can decide whether it is appropriate for a particular person, and the dose and course are set by the doctor.
How to use Malorin
Malorin Syrup is taken by mouth. The doctor decides the dose, how often it is taken and how long the course lasts, based on the condition being treated and the person's age and weight. Follow the doctor's instructions exactly and do not change the amount or stop early on your own. If a dose is missed or you are unsure about anything, ask your doctor or pharmacist.
Side effects of Malorin
At standard doses, Chloroquine is generally well tolerated. Headache and stomach or bowel upset may occur and are usually not serious. With prolonged high doses, side effects can be more serious, including skin rashes, occasional skin colour change or hair loss, difficulty focusing the eyes and blurred vision. Rarely, blood cell problems have been reported. Long-term use carries a risk of eye damage, so tell your doctor about any vision change.
Safety and precautions
Tell your doctor before using Malorin Syrup if you have porphyria, especially with liver problems or cirrhosis, or if you drink alcohol regularly. Eye examinations may be needed during long courses or long-term preventive use. The use of chloroquine during pregnancy should be avoided if possible unless the doctor judges that the benefit outweighs the risk in a threatening infection. People with any ongoing illness, and anyone taking other medicines, should speak to a doctor or pharmacist first.
Frequently asked questions
What is Malorin Syrup used for and what kind of medicine is it?
It is an anti-malarial medicine containing Chloroquine Phosphate. It is used to treat malaria and to prevent and suppress it, and also in some amoebic liver infections and certain joint and skin conditions. The doctor decides if it suits you.
Which medicines may interact with Malorin Syrup?
Chloroquine may interact with phenylbutazone, neostigmine, pyridostigmine, ampicillin and cimetidine. Because other medicines can also interact, tell your doctor or pharmacist about everything you take, including medicines bought without a prescription, before starting this syrup.
How should Malorin Syrup be stored?
Keep the bottle at room temperature in a dry place, away from light. Do not store it where children can reach it, and check with your pharmacist about what to do with any syrup left over after the course.
What is the price of Malorin Syrup?
The listed price is ৳ 12.5. For the current price and availability of the 60 ml bottle, check with the pharmacy or the place where you buy your medicines, as prices can change.
- Strength
- 80 mg/5 ml
Price in Bangladesh
৳ 12.25 ৳ 12.5 2% off unit price
Price updated: 18 Nov 2026
Indications
Chloroquine Phosphate is indicated in the following cases:
- Treatment of malaria
- Prophylaxis and suppression of malaria
- Treatment of amoebic hepatitis and abscess
- Treatment of discoid and systemic and systemic lupus erythematosus
- Treatment of rheumatoid arthritis
Pharmacology
Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.
Dosage & Administration
Treatment of Malaria-
Partially immune adults:
A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.
Partially immune children:
- Under 1 year: 1-2 single dose (in 5 ml spoonful)
- 1-3 years: 3-4 single dose (in 5 ml spoonful)
- 3-6 years: 4-6 single dose (in 5 ml spoonful)
- 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.
Non-immune adults:
- P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
- P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)
Non-immune Children:
Under 1 year:
- 1-2 initial dose (in 5 ml spoonful)
- 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
- 3-4 initial dose (in 5 ml spoonful)
- 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
- 4-6 initial dose (in 5 ml spoonful)
- 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
- 6-9 initial dose (in 5 ml spoonful)
- 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
Prophylaxis and suppression of Malaria-
Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
- Under 1 year: 1 single dose (in 5 ml spoonful)
- 1-3 years: 2 single dose (in 5 ml spoonful)
- 3-6 years: 2-3 single dose (in 5 ml spoonful)
- 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
- Under 1 year: ⅛ adult dose (¼ tablet)
- 1-4 years: ¼ adult dose (½ tablet)
- 4-8 years: ½ adult dose (1 tablet)
- 8-12 years: ¾ adult dose (1.5 tablet)
Interaction
Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.
Contraindications
There is no absolute contraindication to the use of chloroquine.
Side Effects
Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.
The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.
Pregnancy & Lactation
As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.
Precautions & Warnings
Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.
Storage Conditions
Store at room temperature in a dry place, away from light.
Alternative brands of Chloroquine Phosphate
Other brands with the same generic name, cheapest first.
See all 24 brands
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.